Calidi Biotherapeutics, Inc. (CLDI)
0.71
+0.03
(+4.57%)
USD |
NYAM |
Nov 06, 10:05
Calidi Biotherapeutics Market Cap : 1.479M for Nov. 6, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 05, 2026 | 1.414M |
| November 04, 2026 | 1.520M |
| November 03, 2026 | 1.560M |
| November 02, 2026 | 1.370M |
| October 30, 2026 | 1.433M |
| October 29, 2026 | 1.399M |
| October 28, 2026 | 1.462M |
| October 27, 2026 | 1.374M |
| October 26, 2026 | 1.333M |
| October 23, 2026 | 1.343M |
| October 22, 2026 | 1.354M |
| October 21, 2026 | 1.599M |
| October 20, 2026 | 1.604M |
| October 19, 2026 | 1.632M |
| October 16, 2026 | 1.743M |
| October 15, 2026 | 1.812M |
| October 14, 2026 | 1.820M |
| October 13, 2026 | 1.874M |
| October 12, 2026 | 1.978M |
| October 09, 2026 | 2.145M |
| October 08, 2026 | 2.166M |
| October 07, 2026 | 2.103M |
| October 06, 2026 | 2.124M |
| October 05, 2026 | 2.187M |
| October 02, 2026 | 2.249M |
| Date | Value |
|---|---|
| October 01, 2026 | 2.249M |
| September 30, 2026 | 2.228M |
| September 29, 2026 | 2.249M |
| September 28, 2026 | 2.228M |
| September 25, 2026 | 2.353M |
| September 24, 2026 | 2.499M |
| September 23, 2026 | 2.27M |
| September 22, 2026 | 2.312M |
| September 21, 2026 | 2.316M |
| September 18, 2026 | 2.291M |
| September 17, 2026 | 2.645M |
| September 16, 2026 | 2.437M |
| September 15, 2026 | 2.437M |
| September 14, 2026 | 2.541M |
| September 11, 2026 | 2.582M |
| September 10, 2026 | 2.728M |
| September 09, 2026 | 2.832M |
| September 08, 2026 | 2.812M |
| September 04, 2026 | 2.884M |
| September 03, 2026 | 2.812M |
| September 02, 2026 | 2.791M |
| September 01, 2026 | 2.770M |
| August 31, 2026 | 2.791M |
| August 28, 2026 | 2.749M |
| August 27, 2026 | 2.707M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 8.097B |
| Oncolytics Biotech, Inc. | 56.65M |
| Sangamo Therapeutics, Inc. | 47.23M |
| Sarepta Therapeutics, Inc. | 1.880B |
| Anixa Biosciences, Inc. | 104.45M |
Market Cap Related Metrics
| Price to Book Value | 0.4720 |
| Price | 0.71 |
| Earnings Yield | -7.62K% |